- Home
- TEI vs OM Comparison
TEI vs OM Comparison
Compare TEI & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEI
- OM
- Stock Information
- Founded
- TEI 1993
- OM 2003
- Country
- TEI United States
- OM United States
- Employees
- TEI N/A
- OM N/A
- Industry
- TEI Finance Companies
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TEI Finance
- OM Health Care
- Exchange
- TEI Nasdaq
- OM Nasdaq
- Market Cap
- TEI 282.9M
- OM 247.1M
- IPO Year
- TEI N/A
- OM 2020
- Fundamental
- Price
- TEI $6.20
- OM $14.01
- Analyst Decision
- TEI
- OM Hold
- Analyst Count
- TEI 0
- OM 1
- Target Price
- TEI N/A
- OM $22.00
- AVG Volume (30 Days)
- TEI 142.4K
- OM 198.3K
- Earning Date
- TEI 01-01-0001
- OM 11-05-2025
- Dividend Yield
- TEI 10.51%
- OM N/A
- EPS Growth
- TEI N/A
- OM N/A
- EPS
- TEI N/A
- OM N/A
- Revenue
- TEI N/A
- OM $119,304,000.00
- Revenue This Year
- TEI N/A
- OM $12.37
- Revenue Next Year
- TEI N/A
- OM $10.52
- P/E Ratio
- TEI N/A
- OM N/A
- Revenue Growth
- TEI N/A
- OM 2.47
- 52 Week Low
- TEI $4.35
- OM $5.85
- 52 Week High
- TEI $5.39
- OM $25.35
- Technical
- Relative Strength Index (RSI)
- TEI 65.42
- OM 46.20
- Support Level
- TEI $6.07
- OM $13.01
- Resistance Level
- TEI $6.13
- OM $14.22
- Average True Range (ATR)
- TEI 0.07
- OM 0.58
- MACD
- TEI 0.01
- OM 0.21
- Stochastic Oscillator
- TEI 93.59
- OM 74.91
About TEI Templeton Emerging Markets Income Fund Inc.
Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments, and Money Market Funds.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.